
The WFH Guidelines for the Management of Hemophilia: AAV Gene Therapy
The WFH Guidelines for the Management of Hemophilia: AAV Gene Therapy provide the first comprehensive, evidence-based recommendations to support the
Year: 2020
Language: English
Author(s): w
In this session from the WFH 2020 Virtual Summit, Saliou Diop, Ampaiwan Chuansumrit, Silvia Riva and Ahmad Tarawah discuss:
The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.
The WFH does not promote any particular pharmaceutical product and any mention of any commercial brand in this presentation is strictly for educational purposes.

The WFH Guidelines for the Management of Hemophilia: AAV Gene Therapy provide the first comprehensive, evidence-based recommendations to support the

Raising funds requires careful research and detailed planning, as well as creativity and good business practices. The second edition of

The 2026 version is available in: SpanishThe 2018 version booklet is available in: English, Arabic, French, Russian, Spanish, Simplified Chinese Using

In celebration of International Women’s Day, the World Federation of Hemophilia (WFH) hosted a webinar focused on postpartum hemorrhage and

A 3ª edição do Manual de Laboratório da WFH é o guia definitivo para o diagnóstico preciso da hemofilia e

People with bleeding disorders continue to face significant challenges in diagnosis, access to treatment and care around the world. To